A novel pocket in 14-3-3e{open} is required to mediate specific complex formation with cdc25C and to inhibit cell cycle progression upon activation of checkpoint pathways

Experimental Cell Research

Volumn 315, Issue 8, 2009, Pages 1448-1457

  Telles, Elphine ^a   Hosing, Amol S ^a   Kundu, Samrat T ^a   Venkatraman, Prasanna ^a   Dalal, Sorab N ^a  

^a CANCER RESEARCH INSTITUTE   (India)

Author keywords

14 3 3 epsilon; cdc25C; Cell cycle; Checkpoints; Mitosis

Indexed keywords

14 3 3 EPSILON PROTEIN; CDC25C PHOSPHATASE; CHIMERIC PROTEIN; LIGAND; PHENYLALANINE; PROTEIN 14 3 3; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; ENZYME BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR DYNAMICS; MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE;

EID: 64449088193     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.01.018     Document Type: Article

References (35)

1. Gautier J., Solomon M.J., Booher R.N., Bazan J.F., and Kirschner M.W. cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67 (1991) 197-211
2. Chaturvedi P., Eng W.K., Zhu Y., Mattern M.R., Mishra R., Hurle M.R., Zhang X., Annan R.S., Lu Q., Faucette L.F., Scott G.F., Li X., Carr S.A., Johnson R.K., Winkler J.D., and Zhou B.B. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18 (1999) 4047-4054
3. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., and Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277 (1997) 1501-1505
4. Sanchez Y., Wong C., Thoma R.S., Richman R., Wu Z., Piwnica-Worms H., and Elledge S.J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277 (1997) 1497-1501
5. Dalal S.N., Schweitzer C.M., Gan J., and DeCaprio J.A. Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol. Cell. Biol. 19 (1999) 4465-4479
6. Dougherty M.K., and Morrison D.K. Unlocking the code of 14-3-3. J. Cell. Sci. 117 (2004) 1875-1884
7. Tzivion G., Gupta V.S., Kaplun L., and Balan V. 14-3-3 proteins as potential oncogenes. Semin. Cancer Biol. 16 (2006) 203-213
8. Liu D., Bienkowska J., Petosa C., Collier R.J., Fu H., and Liddington R. Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 376 (1995) 191-194
9. Wilker E.W., Grant R.A., Artim S.C., and Yaffe M.B. A structural basis for 14-3-3sigma functional specificity. J. Biol. Chem. 280 (2005) 18891-18898
10. Xiao B., Smerdon S.J., Jones D.H., Dodson G.G., Soneji Y., Aitken A., and Gamblin S.J. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376 (1995) 188-191
11. Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V., Grossmann J.G., Sundstrom M., Doyle D.A., and Elkins J.M. Structural basis for protein-protein interactions in the 14-3-3 protein family. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17237-17242
12. Dalal S.N., Yaffe M.B., and DeCaprio J.A. 14-3-3 family members act coordinately to regulate mitotic progression. Cell Cycle (2004) 3
13. Ge L., and Rudolph P. Simultaneous introduction of multiple mutations using overlap extension PCR. Biotechniques 22 (1997) 28-30
14. Skaar J.R., Arai T., and DeCaprio J.A. Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development. Mol. Cell. Biol. 25 (2005) 5579-5589
15. Hosing A.S., Kundu S.T., and Dalal S.N. 14-3-3 gamma is required to enforce both the incomplete S phase and G2 DNA damage checkpoints. Cell Cycle 7 (2008) 3171-3179
16. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., and Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401 (1999) 616-620
17. Kundu S.T., Gosavi P., Khapare N., Patel R., Hosing A.S., Maru G.B., Ingle A., Decaprio J.A., and Dalal S.N. Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis. Int. J. Cancer 123 (2008) 2303-2314
18. Spector D.L., R.D. G., and Leinwand L.A. Cells: A Laboratory Manual (1998), Cold Spring Harbour Laboratory
19. Roy D., Angelini N.L., Fujieda H., Brown G.M., and Belsham D.D. Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin. Endocrinology 142 (2001) 4711-4720
20. Saxena S., Yuan P., Dhar S.K., Senga T., Takeda D., Robinson H., Kornbluth S., Swaminathan K., and Dutta A. A dimerized coiled-coil domain and an adjoining part of geminin interact with two sites on Cdt1 for replication inhibition. Mol. Cell 15 (2004) 245-258
21. Konishi H., Nakagawa T., Harano T., Mizuno K., Saito H., Masuda A., Matsuda H., Osada H., and Takahashi T. Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers. Cancer Res. 62 (2002) 271-276
22. Chaudhri M., Scarabel M., and Aitken A. Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem. Biophys. Res. Commun. 300 (2003) 679-685
23. Graves P.R., Lovly C.M., Uy G.L., and Piwnica-Worms H. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene 20 (2001) 1839-1851
24. Krek W., and DeCaprio J.A. Cell synchronization. Methods Enzymol. 254 (1995) 114-124
25. Yang J., Winkler K., Yoshida M., and Kornbluth S. Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J. 18 (1999) 2174-2183
26. Lopez-Girona A., Furnari B., Mondesert O., and Russell P. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397 (1999) 172-175
27. Kumagai A., and Dunphy W.G. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev. 13 (1999) 1067-1072
28. Zeng Y., Forbes K.C., Wu Z., Moreno S., Piwnica-Worms H., and Enoch T. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature 395 (1998) 507-510
29. Zeng Y., and Piwnica-Worms H. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol. Cell Biol. 19 (1999) 7410-7419
30. Wang W., and Shakes D.C. Molecular evolution of the 14-3-3 protein family. J. Mol. Evol. 43 (1996) 384-398
31. Shen Y.H., Godlewski J., Bronisz A., Zhu J., Comb M.J., Avruch J., and Tzivion G. Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding. Mol. Biol. Cell 14 (2003) 4721-4733
32. Powell D.W., Rane M.J., Joughin B.A., Kalmukova R., Hong J.H., Tidor B., Dean W.L., Pierce W.M., Klein J.B., Yaffe M.B., and McLeish K.R. Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol. Cell. Biol. 23 (2003) 5376-5387
33. Muslin A.J., Tanner J.W., Allen P.M., and Shaw A.S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84 (1996) 889-897
34. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., Gamblin S.J., Smerdon S.J., and Cantley L.C. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91 (1997) 961-971
35. Lodygin D., and Hermeking H. Epigenetic silencing of 14-3-3sigma in cancer. Semin. Cancer Biol. 16 (2006) 214-224